217 related articles for article (PubMed ID: 29666117)
21. Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
Chung C
J Oncol Pharm Pract; 2020 Jun; 26(4):943-966. PubMed ID: 31964218
[TBL] [Abstract][Full Text] [Related]
22. Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.
Fujisawa M; Chiba S; Sakata-Yanagimoto M
J Clin Exp Hematop; 2017; 57(3):109-119. PubMed ID: 29279549
[TBL] [Abstract][Full Text] [Related]
23. c-kit Expression and mutations in peripheral T cell lymphomas, except for extra-nodal NK/T cell lymphomas.
Choe YS; Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Do YR; Kwon KY; Song HS; Lee MH; Park TI
Leuk Lymphoma; 2006 Feb; 47(2):267-70. PubMed ID: 16321856
[TBL] [Abstract][Full Text] [Related]
24. Pathology and biology of peripheral T-cell lymphomas.
de Leval L; Gaulard P
Histopathology; 2011 Jan; 58(1):49-68. PubMed ID: 21261683
[TBL] [Abstract][Full Text] [Related]
25. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
de Leval L; Gaulard P
Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
[TBL] [Abstract][Full Text] [Related]
26. [Molecular abnormalities in lymphomas].
Delsol G
Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
[TBL] [Abstract][Full Text] [Related]
27. New insights in the pathogenesis of T-cell lymphomas.
Lemonnier F; Gaulard P; de Leval L
Curr Opin Oncol; 2018 Sep; 30(5):277-284. PubMed ID: 30028743
[TBL] [Abstract][Full Text] [Related]
28. Targeted based therapy in nodal T-cell lymphomas.
Chihara D; Miljkovic M; Iyer SP; Vega F
Leukemia; 2021 Apr; 35(4):956-967. PubMed ID: 33664464
[TBL] [Abstract][Full Text] [Related]
29. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
Lee PH; Weng SW; Liu TT; You HL; Liao CK; Wang MC; Huang WT
Exp Mol Pathol; 2019 Oct; 110():104294. PubMed ID: 31394087
[TBL] [Abstract][Full Text] [Related]
30. Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma.
Xie C; Li X; Zeng H; Qian W
Exp Hematol Oncol; 2020 Nov; 9(1):30. PubMed ID: 33292562
[TBL] [Abstract][Full Text] [Related]
31. Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.
Menon MP; Nicolae A; Meeker H; Raffeld M; Xi L; Jegalian AG; Miller DC; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2015 Dec; 39(12):1719-1729. PubMed ID: 26379152
[TBL] [Abstract][Full Text] [Related]
32. Pathology of peripheral T-cell lymphomas: where do we stand?
Gaulard P; de Leval L
Semin Hematol; 2014 Jan; 51(1):5-16. PubMed ID: 24468311
[TBL] [Abstract][Full Text] [Related]
33. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
[TBL] [Abstract][Full Text] [Related]
34. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
35. Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.
Yoo HY; Kim P; Kim WS; Lee SH; Kim S; Kang SY; Jang HY; Lee JE; Kim J; Kim SJ; Ko YH; Lee S
Haematologica; 2016 Jun; 101(6):757-63. PubMed ID: 26819049
[TBL] [Abstract][Full Text] [Related]
36. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
[TBL] [Abstract][Full Text] [Related]
37. Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
Ondrejka SL; Grzywacz B; Bodo J; Makishima H; Polprasert C; Said JW; Przychodzen B; Maciejewski JP; Hsi ED
Am J Surg Pathol; 2016 Mar; 40(3):335-41. PubMed ID: 26574844
[TBL] [Abstract][Full Text] [Related]
38. Peripheral T-cell lymphomas.
Macon WR
Hematol Oncol Clin North Am; 2009 Aug; 23(4):829-42. PubMed ID: 19577171
[TBL] [Abstract][Full Text] [Related]
39. New biomarkers in T-cell lymphomas.
Bisig B; Gaulard P; de Leval L
Best Pract Res Clin Haematol; 2012 Mar; 25(1):13-28. PubMed ID: 22409820
[TBL] [Abstract][Full Text] [Related]
40. Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma.
Zing NPC; Fischer T; Zain J; Federico M; Rosen ST
Oncology (Williston Park); 2018 Aug; 32(8):e83-e89. PubMed ID: 30153323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
